Bafna Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication in connection with Audited Financial Results of the Company for the Quarter and Year ended March 31, 2025 published in "Business Standard" and "Makkal Kural" on May 28, 2025
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bafna Pharmaceuticals Limited has informed the stock exchanges that it published the extract of its Audited Financial Results for the quarter and financial year ended March 31, 2025 in two newspapers — 'Business Standard' (English) and 'Makkal Kural' (Tamil) — on May 28, 2025. The disclosure is being made under Regulation 30 of the SEBI (LODR) Regulations, 2015, as a regulatory compliance step. The letter is signed by Mohanachandran A, Company Secretary & Compliance Officer, and addressed to both BSE (Scrip Code: 532989) and NSE (Scrip Code: BAFNAPH). This filing is essentially a confirmation that the company has met its newspaper publication requirement for audited results; the detailed numbers were published in the newspapers themselves.
This is a routine procedural/compliance filing and does not contain any new material information beyond confirming the newspaper publication of the audited FY25 results. Shareholders should refer to the separately filed audited financial results for the actual performance numbers.